8
Oct
2024

SAVIPHARM JSC.

Exhibitor at CPHI Milan 2024 stand 7C74, Contract Manufacturing and Services
About Us

Savipharm J.S.C (SVP), was founded by Mr. Tran Tuu in 8/2005 in Ho Chi Minh City, Vietnam. SVP's OSD factory is certified Japanese GMP since 12/2010, EU-GMP since 11/2019. With contract between SVP & GSK, SVP has exported to the Japan since 2010, continuing expanding to ASEAN countries. SVP is investing in new High-tech Oncology Factory (2 production lines: OSD and injection - lyophilized). SVP is ready to discuss with partners about cooperation options: a) importing pharmaceutical ingredients and exporting SVP finished products, b) Franchisee-t...

  • VN
  • 2018
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 7C74, Contract Manufacturing and Services

Products Featured at CPHI Milan 2024

  • Contract manufacture and supply

    Product Contract manufacture and supply

    SaVipharm is willing to cooperate with partners in manufacture and supply of pharmaceuticals and dietary supplements. For more detail, please contact us.
  • Franchising and Technology Transfer

    Product Franchising and Technology Transfer

    SVP is willing to cooperate with partners in franchising products and Technology transfer. For more detail, please contact us.
  • Research and Development of new products at SVP High-tech R&D centre

    Product Research and Development of new products at SVP High-tech R&D centre

    SVP is willing to cooperate with partners in Research and Development of new products at SVP High-tech R&D centre, including high-tech products, special formulations, liquid products, biopharmaceutical products, oncology products and technology transfer support. For more detail, please contact us.